title: Symptomatic hyponatremia related to the use of propafenone.
authors.forename: L Y
authors.initials: LY
authors.lastname: Dirix
authors.forename: C
authors.initials: C
authors.lastname: Moeremans
authors.forename: H
authors.initials: H
authors.lastname: Fierens
authors.forename: D
authors.initials: D
authors.lastname: Dielen
authors.forename: C
authors.initials: C
authors.lastname: Vrints
authors.forename: E
authors.initials: E
authors.lastname: Van Agt
authors.forename: J
authors.initials: J
authors.lastname: Snoeck
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced*; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D011405:Propafenone / Q000009:adverse effects* / Q000627:therapeutic use; D013611:Tachycardia, Atrioventricular Nodal Reentry / Q000188:drug therapy*; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*
chemical_list: D011405:Propafenone